RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
Lire cette page en: English · العربية · Français · Português
Register / Egypt / DEA-EG-2026-0014
Egyptian Drug Authority · Egypt
DEA-EG-2026-0014
Tier 1 · Regulator-publishedUnclassifiedMise en garde au publicStatus · active
Issuing authority
Egyptian Drug Authority (EDA)
Authority reference
Periodic report no.(14) For 2026
Date issued
Mar 2026
Recorded by us
2026-09-06 19:45:29 UTC
Produit
Amoxicillin Trihydrate20 % (W.S.P) Doxycycline 20% (W.S.P) Ampicillin Trihydrate 20% (W.S.P) Neobiotic(W.S.P)
INN / active substance
Not stated by the issuing authority
Dosage form
Not stated by the issuing authority
Strength
Not stated by the issuing authority
Fabricant
Not stated by the issuing authority
Manufacturer country
Not stated by the issuing authority
MAH or importer
Not stated by the issuing authority
Numéros de lot
2401123 · 2402127
Dates de péremption
Not published with the notice
Action type
Mise en garde au public
Classification
Not stated by the issuing authority
Indicative severity
Not assessed by Drug Eye Africa
Defect category
Falsifié
Product type
Not stated by the issuing authority
ATC code
Not stated by the issuing authority
Affected markets
Egypt — no market beyond the issuing country was named on the notice
Cross-border event
Not linked to a cross-border event
Texte de l’avis
Amoxicillin Trihydrate20 % (W.S.P) Doxycycline 20% (W.S.P) Ampicillin Trihydrate 20% (W.S.P) Neobiotic( W.S.P) 2401123 - 2401123 2402127 1/2024 11/2023 1/2024 2/2024 1/2027 11/2026 1/2027 2/2027 شركة النيل للادوية و الصناعات الكيماوية إحتمالية تداول عبوات مجهولة المصدر ومقلدة من الاصناف الموضحة بعاليه و ذلك بناء علي ما ورد الينا من شركة النيل للادوية و الصناعات الكيماوية وقف تداول و ضبط وتحريز المستحضر المغشوش في حالة الشك في المستحضر الصيدلى يتم الرجوع الى هيئة الدواء المصرية سواء بالإتصال بالخط الساخن 15301او الموقع الإلكترونى الخاص بالهيئة. يمكن الضغط على الرابطللإطلاع على الصور الخاصة بالمستحضر المقلد. مارس2026 منشور غش تجاري اسم المستحضر الشركة المصنعة المدونة علي العبوات سبب التحذير الإجراءات التصحيحية نصائح للمستهلكين هذا التنبيه خاص بالتشغيلات الواردة في المنشور فقط ولا ينطبق على تداول المستحضر بشكل عام التشغيلة المدونه على العبوات تاريخ الانتاج المدون على العبوات تاريخ الانتهاء المدون على العبوات
Original language: ar
Texte de l’avis en anglais
Notice. Amoxicillin Trihydrate 20% (W.S.P), Doxycycline 20% (W.S.P), Ampicillin Trihydrate 20% (W.S.P) and Neobiotic (W.S.P), of the Nile Company for Pharmaceuticals and Chemical Industries, batches 2401123 and 2402127, manufactured between 11/2023 and 2/2024 with expiries between 11/2026 and 2/2027. The extracted text refers to a possibility, and the wording is not complete enough to render it faithfully.
Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
Statut
En vigueur
Superseded by
Not superseded. This is the current version.
Version
11

Provenance

Verification tier 1

Where this record came from, and what is held to show it.

Copy of the source
Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.
Ask us for it and check it against the fingerprint below.
Fingerprint
ef694b8aabaad65b14cc43c1c63437ca75a0265eed837026326191379f0ba629
SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
Copy taken
2026-09-06 20:48:52 UTC

Related actions elsewhere

Same stated defect
ReferenceDateCountryProductBatchesActionClassSource
DEA-XXX-2026-000303 Jul 2026XXDARZALEX (daratumumab)MYS7381 · STV1K01Public warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0070Jul 2026EGTagrisso 80 mg film-coated tabletsFESTPublic warningUnclassifiedTier 1 · Regulator-published
DEA-XXX-2026-000216 Jun 2026XXJAKAVI (ruxolitinib)none publishedPublic warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0062Jun 2026EGCOLOVERIN-D 30 film Coated Tablets251035APublic warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0061Jun 2026EGFLOPADEX 8mg Hard gelatin capsules 302504626Public warningUnclassifiedTier 1 · Regulator-published
DEA-EG-2026-0060Jun 2026EGTears Guard Artificial Tears & Lubricant (Sterile Ophthalmic Solution)0425118Public warningUnclassifiedTier 1 · Regulator-published
Cite this record
Drug Eye Africa (2026). DEA-EG-2026-0014: Amoxicillin Trihydrate20 % (W.S.P) Doxycycline 20% (W.S.P) Ampicillin Trihydrate 20% (W.S.P) Neobiotic(W.S.P) — Mise en garde au public, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2026/dea-eg-2026-0014

Version history

v5Manufacturer removed: the notice describes packs of unknown origin; the notice describes the packaging as counterfeit (correction)
Corrections appear here and in the site-wide log. Records are superseded, never deleted.

Verification

Tier 1Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.

Indexing

This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.